Caspofungin versus liposomal amphotericin B for empirical therapy.
Kontoyiannis
Dimitrios P
DP
Lewis
Russell E
RE
D000666:Amphotericin B / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000150:complications / Q000188:drug therapy*; D000077336:Caspofungin; D054714:Echinocandins; D006801:Humans; D055666:Lipopeptides; D009503:Neutropenia / Q000209:etiology; D009504:Neutrophils / Q000187:drug effects; D010456:Peptides, Cyclic / Q000627:therapeutic use*
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010456:Peptides, Cyclic; D000666:Amphotericin B; D000077336:Caspofungin